bioAffinity Technologies, Inc. (BIAF) vs Onconetix, Inc. (ONCO)
A side-by-side comparison of bioAffinity Technologies, Inc. and Onconetix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIAF
bioAffinity Technologies, Inc.
$6.07HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
ONCO
Onconetix, Inc.
$0.68HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
Total return — BIAF vs ONCO
growth of $100 · dividends reinvested · last 4yBIAF -99.8% (-79.8%/yr)ONCO -100.0% (-96.5%/yr)BIAF compounded faster over this window
Log scale — wide-divergence pair
BIAF ONCO
BIAF vs ONCO: by the numbers
- •BIAF is the larger company ($3M vs $2M market cap).
- •Both run net losses; BIAF's is the smaller (-257.33% vs -1578.79% net margin).
Metrics side by side
Valuation
| Metric | BIAF | ONCO |
|---|---|---|
| P/S ratio | 0.43 | 3.76 |
| P/B ratio | 0.67 | 0.18 |
Profitability
| Metric | BIAF | ONCO |
|---|---|---|
| Gross margin | 23.21% | 80.40% |
| Operating margin | -171.58% | -778.16% |
| Net margin | -257.33% | -1578.79% |
| ROE | -402.92% | -75.70% |
| ROIC | -237.93% | -59.84% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.